ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1601

Satisfaction with Telemedicine in Immunosuppressed Children and Young Adults with Autoimmune Disease During the COVID 19 Pandemic: Are Their Needs Really Met? Preliminary Data from a Single Institution

Lakshmi Moorthy1, Lauren Freidenrich1, Lisa Mikesell2, Sarah Fadem2, Vikram Bhise1, Richard Brodsky1, Ellen Cahill1, Joann Carlson1, Yue Hao1, Daniel Horton1, Vivien Hsu1, Editt Rodriguez1, Christian Salazar3, Cynthia Salvant1 and Lawrence Kleinman1, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2Rutgers Department of Communication, New Brunswick, NJ, 3NYU Dept. of Epi. and Health Promotion, New York, NY

Meeting: ACR Convergence 2021

Keywords: Access to care, autoimmune diseases, COVID-19

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster IV: COVID-19 (1589–1613)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: COVID-19 can lead to severe and life-threatening complications, which is particularly unnerving for patients with autoimmune disease (AID) on immunosuppressive therapy. Telemedicine has enabled these patients to receive healthcare while socially distant. We describe preliminary data regarding the capacity of telemedicine to meet the healthcare needs of patients with AID who are immunosuppressed.

Methods: This cross-sectional survey included immunosuppressed young adults with AID and parents of immunosuppressed children with AID. The validated Local Inventory of Needs and Knowledge (LINK) survey with a 5-point Likert scale (completely true to completely untrue) was used to assess met and unmet medical and non-medical needs. LINK was modified to address the impact of the pandemic on access to medical care, experience with telemedicine, and health-related behaviors in immunosuppressed AID patients. Consistent with LINK’s intention, responses were dichotomized at the extremes, either completely true (5) versus all other responses, or not at all true (1) versus all other responses, depending upon the stem’s framing. See figure 1 for a sample of a LINK survey question.

Results: The first 29 respondents were 17 young adults and 12 parents. Patient (7-24 years old) diagnoses included: lupus (n=7), multiple sclerosis (n=6), juvenile arthritis (n=2), uveitis (n=2), vasculitis (n=2), minimal change disease (n=2), neuromyelitis (n=2), nephrotic syndrome (n=1), Henoch-Schonlein purpura (n=1), dermatomyositis (n=1), focal segmental glomerular sclerosis (n=1), post renal transplant (n=1), and systemic sclerosis (n=1).

Within this sample, 24% worried about going to a doctor’s office/hospital due to immunosuppressed status. Fear of getting COVID-19 prevented 17% from seeking in-person medical care (Fig 2). Almost all (97%) had access to Wi-Fi, 71% felt comfortable with the idea of seeing a doctor using telemedicine and 59% found it to be a convenient form of healthcare delivery. Many (69%) felt telemedicine was “easy to use” and 59% reported that telemedicine minimized “pandemic-associated stress.” Most (72%) believed telemedicine saved time. While 68% of patients were comfortable with in-person appointments, 48% of patients felt “more comfortable with telemedicine appointments during the pandemic.” Only 55% thought “all of [their] important healthcare needs were met (Fig 2).” Patients also reported non-medical issues such as difficulties with access to adequate food and housing (data analysis is underway). Responses from young adults and parents were similar.

Conclusion: In this sample of immunosuppressed patients with AID and their parents, a majority identified telemedicine as a convenient and effective alternative to in-person appointments during the pandemic. While respondents expressed satisfaction with telemedicine services that were delivered, nearly half (45%) reported that they remained with unmet needs, suggesting that satisfaction alone is insufficient to assess the adequacy of telemedicine in this population. Data collection is ongoing to understand the unmet needs and drawbacks of telemedicine.

Sample of LINK survey question and response set (only 1 question out of several questions has been included)

Perceptions on Telehealth based on the LINK survey responses (n=29)


Disclosures: L. Moorthy, Bristol Myer Squibb, 5; L. Freidenrich, None; L. Mikesell, None; S. Fadem, None; V. Bhise, None; R. Brodsky, None; E. Cahill, None; J. Carlson, None; Y. Hao, None; D. Horton, Danisco USA Inc., 5; V. Hsu, None; E. Rodriguez, None; C. Salazar, None; C. Salvant, None; L. Kleinman, None.

To cite this abstract in AMA style:

Moorthy L, Freidenrich L, Mikesell L, Fadem S, Bhise V, Brodsky R, Cahill E, Carlson J, Hao Y, Horton D, Hsu V, Rodriguez E, Salazar C, Salvant C, Kleinman L. Satisfaction with Telemedicine in Immunosuppressed Children and Young Adults with Autoimmune Disease During the COVID 19 Pandemic: Are Their Needs Really Met? Preliminary Data from a Single Institution [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/satisfaction-with-telemedicine-in-immunosuppressed-children-and-young-adults-with-autoimmune-disease-during-the-covid-19-pandemic-are-their-needs-really-met-preliminary-data-from-a-single-institutio/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/satisfaction-with-telemedicine-in-immunosuppressed-children-and-young-adults-with-autoimmune-disease-during-the-covid-19-pandemic-are-their-needs-really-met-preliminary-data-from-a-single-institutio/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology